Clinical trials
Stomach Neoplasms trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 11 |
| Amgen | 2 |
| Hoffmann-La Roche | 2 |
| Taiho Oncology, Inc. | 2 |
| ASLAN Pharmaceuticals | 1 |
| Arbele Pty Ltd | 1 |
| Arcus Biosciences, Inc. | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| BeiGene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 40 |
| Adenocarcinoma | 3 |
| Cholangiocarcinoma | 2 |
| Esophageal Neoplasms | 2 |
| Gastritis, Atrophic | 2 |
| Gastrointestinal Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.